Saturday, July 4, 2026

Supply Concerns Raised from Amid Middle East Conflict; Government Says No Immediate Shortage

Concerns rise over pharmaceutical supply disruptions due to Middle East conflict; authorities monitor and prepare for potential shortages.

North Korea Prepares to Launch More Reconnaissance Satellites

While South Korea's military plans to launch...

U.S. Lifts Export Controls: What This Means for Claude Mythos 5 and Claude Fable 5 in Korea

The U.S. lifts export controls on top AI models, restoring access to Mythos and Claude families for South Korea's users.

Tag: SK Biopharm

SK Biopharm’s Xcopri: How This CNS Drug is Redefining Global Market Strategies

SK Biopharm aims to enhance its CNS leadership and foster Asian biotech connections with global markets through open innovation and collaboration.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us